Publicaciones en las que colabora con María Sanjurjo Sáez (17)

2024

  1. Treatment with Rasburicase in Hospitalized Patients with Cardiorenal Syndrome: Old Treatment, New Scenario

    International Journal of Molecular Sciences, Vol. 25, Núm. 6

2023

  1. Hacia la excelencia en la atención farmacéutica al paciente quirúrgico

    Farmacia hospitalaria : organo oficial de expresion cientifica de la Sociedad Espanola de Farmacia Hospitalaria, Vol. 47, Núm. 1, pp. 26-30

  2. Presence of metallic components in transdermal drug delivery systems and risk of skin burns

    Farmacia Hospitalaria

2022

  1. PCSK9 inhibitors revisited: Effectiveness and safety of PCSK9 inhibitors in a real-life Spanish cohort

    Biomedicine and Pharmacotherapy, Vol. 146

2021

  1. Clinical evaluation of pulmonary hypertension using patient-reported outcomes: a cross-sectional study

    BMC Pulmonary Medicine, Vol. 21, Núm. 1

  2. Dpyd exome, mrna expression and uracil levels in early severe toxicity to fluoropyrimidines: An extreme phenotype approach

    Journal of Personalized Medicine, Vol. 11, Núm. 8

  3. Levels of tacrolimus after treatment for chronic hepatitis C with direct antiviral agents in solid organ transplant recipients

    International Journal of Clinical Pharmacy, Vol. 43, Núm. 3, pp. 731-736

2020

  1. Genetic Predictors of Long-term Response to Antitumor Necrosis Factor Agents in Pediatric Inflammatory Bowel Disease

    Journal of pediatric gastroenterology and nutrition, Vol. 71, Núm. 4, pp. 508-515

  2. Improving surgical antibiotic prophylaxis adherence and reducing hospital readmissions: A bundle of interventions including health information technologies

    European Journal of Hospital Pharmacy, Vol. 27, Núm. 4, pp. 237-242

  3. New DPYD variants causing DPD deficiency in patients treated with fluoropyrimidine

    Cancer Chemotherapy and Pharmacology, Vol. 86, Núm. 1, pp. 45-54

  4. Topical Administration of Amphotericin B as an Effective Adjuvant Treatment for a Deep Fungal Infection of Diabetic Foot Injury

    American journal of therapeutics, Vol. 27, Núm. 6, pp. e670-e671

2019

  1. Comments on: “Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan”

    Pharmacological Research

2018

  1. Clinical utility of ABCB1 genotyping for preventing toxicity in treatment with irinotecan

    Pharmacological Research, Vol. 136, pp. 133-139

  2. Drug cost avoidance resulting from breast cancer clinical trials

    European Journal of Clinical Pharmacy, Vol. 20, Núm. 1, pp. 6-10

2016

  1. Efficiency of biological therapies in patients with moderate to severe psoriasis: Impact of a pharmacotherapeutic protocol

    Journal of Dermatological Treatment, Vol. 27, Núm. 3, pp. 198-202

  2. Impact of medication adherence on the effectiveness of deferasirox for the treatment of transfusional iron overload in myelodysplastic syndrome

    Journal of Clinical Pharmacy and Therapeutics, Vol. 41, Núm. 1, pp. 59-63

2015

  1. Coste-efectividad y seguridad de telaprevir y boceprevir para el tratamiento de la hepatitis C crónica en la práctica clínica

    Gastroenterologia y Hepatologia, Vol. 38, Núm. 10, pp. 575-582